Financial

PlaqueTec Closes $5 Million Financing

Share by Ken Dropiewski on

More in Financial:

Share this story

CAMBRIDGE, England–(BUSINESS WIRE)–PlaqueTec, a medtech company pioneering intracoronary liquid biopsy to identify inflammatory drivers of cardiovascular disease (CVD), today announced it has raised $5 million. The oversubscribed financing round was funded entirely by the Company’s existing investor base. The investment will support the continued build-out of PlaqueTec’s proprietary cardiovascular data lake, BioCarta, a growing repository of unique intracoronary proteomic and clinical data. B

See full post here as originally published on this site

Ken has been in the cardiac, vascular, and interventional space for over 20 years. He is a Partner with McDermott + Bull Executive Search, recognized by Forbes as one of the industry's best with offices across North America and in Europe. Ken is hired by innovative cardiovascular device and biotech companies to help build their best teams possible at the executive level. Prior to search, Ken had an award winning commercial career at Boston Scientific and Johnson & Johnson to include such prestigious awards as President's Club, Ring Club, and Grand Awards. dropiewski@mbexec.com

Leave a Comment

Your email address will not be published. Required fields are marked *

*